Skip to main content

Table 3 Experimental design for the assessment of the effects of matrine on the PAMs inflammatory response

From: Matrine inhibits IL-1β secretion in primary porcine alveolar macrophages through the MyD88/NF-κB pathway and NLRP3 inflammasome

 Cell control group (Cell)Transfection reagents group (RNA-0)5′UTR RNA + LPS group (RNA-4 + LPS)Matrine treatment group (MT)Dexamethasone treatment group (DEX)
Transfection reagents++++
4 μg 5′UTR RNA+++
1 μg/mL LPS+++
Matrine+
Dexamethasone+
  1. At 6 h post-transfection, the transfected medium was removed in the matrine or dexamethasone treatment groups. Fresh medium with 0.4 mg/mL matrine was added to the matrine treatment group, and fresh medium with 0.04 mg/mL dexamethasone was added to the dexamethasone treatment group.